Orthofix Medical Inc (OFIX)
12.38
-0.12
(-0.96%)
USD |
NASDAQ |
Jun 14, 16:00
12.38
0.00 (0.00%)
After-Hours: 20:00
Orthofix Medical Research and Development Expense (Quarterly): 19.49M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.49M |
| December 31, 2023 | 18.94M |
| September 30, 2023 | 18.56M |
| June 30, 2023 | 19.42M |
| March 31, 2023 | 23.31M |
| December 31, 2022 | 13.15M |
| September 30, 2022 | 11.94M |
| June 30, 2022 | 12.76M |
| March 31, 2022 | 11.21M |
| December 31, 2021 | 13.24M |
| September 30, 2021 | 12.36M |
| June 30, 2021 | 13.12M |
| March 31, 2021 | 10.90M |
| December 31, 2020 | 10.36M |
| September 30, 2020 | 9.962M |
| June 30, 2020 | 8.765M |
| March 31, 2020 | 9.964M |
| December 31, 2019 | 8.446M |
| September 30, 2019 | 7.982M |
| June 30, 2019 | 8.98M |
| March 31, 2019 | 9.229M |
| December 31, 2018 | 8.792M |
| September 30, 2018 | 9.598M |
| June 30, 2018 | 7.891M |
| March 31, 2018 | 6.937M |
| Date | Value |
|---|---|
| December 31, 2017 | 8.454M |
| September 30, 2017 | 6.935M |
| June 30, 2017 | 6.887M |
| March 31, 2017 | 7.424M |
| December 31, 2016 | 7.509M |
| September 30, 2016 | 6.858M |
| June 30, 2016 | 6.796M |
| March 31, 2016 | 7.64M |
| December 31, 2015 | 7.57M |
| September 30, 2015 | 6.523M |
| June 30, 2015 | 6.451M |
| March 31, 2015 | 5.845M |
| December 31, 2014 | 6.176M |
| September 30, 2014 | 6.572M |
| June 30, 2014 | 6.313M |
| March 31, 2014 | 5.933M |
| December 31, 2013 | 6.115M |
| September 30, 2013 | 6.361M |
| June 30, 2013 | 8.551M |
| March 31, 2013 | 5.741M |
| December 31, 2012 | 5.417M |
| September 30, 2012 | 6.858M |
| June 30, 2012 | 9.252M |
| March 31, 2012 | 7.05M |
| December 31, 2011 | 5.206M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
7.982M
Minimum
Sep 2019
23.31M
Maximum
Mar 2023
13.14M
Average
12.15M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 366.00M |
| Perspective Therapeutics Inc | 7.452M |
| Xtant Medical Holdings Inc | 0.527M |
| Asensus Surgical Inc | 8.091M |
| Catheter Precision Inc | 0.037M |